This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-311535-ppkwd1kp | Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid? |
| cord-011333-yyhwtnza | based on systematic review US can not be used to predict the presence or severity of hepatic steatosis in severely obese adolescents Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD Prevalence of nonalcoholic fatty liver disease in children with obesity Pediatric nonalcoholic fatty liver disease: a report from the expert committee on nonalcoholic fatty liver disease( ECON) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease Metformin use in children with nonalcoholic fatty liver disease: an open- label, 24-month, observational pilot study Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial How can physical activity be promoted among children and adolescents? |
| cord-011333-yyhwtnza | which cut- offs should we use? |
| cord-329308-ipui7lo6 | EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus Emerging WuHan( COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 COVID-19 and diabetes: can DPP4 inhibition play a role? |
| cord-329308-ipui7lo6 | intestinal inflammation Angiotensin- converting enzyme 2 is a functional receptor for the SARS coronavirus COVID-19, ACE2, and the cardiovascular consequences Angiotensin- converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS- CoV-2: a double- edged sword? |
| cord-344614-5zcylf6k | The association between body- mass index and patient outcome shock: A retrospective cohort study Obesity paradox in cardiovascular disease: where do we stand? |
| cord-344614-5zcylf6k | The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions? |
| cord-034066-fsp7e5x5 | Parent perspectives on attrition from tertiary care pediatric weight management programs Telemedicine and pediatric obesity treatment: review of literature and lessons learnt Multidisciplinary pediatric obesity clinic via telemedicine within the Los Angeles metropolitan area: lessons learned Mobile apps for pediatric obesity prevention and treatment, healthy eating, and physical activity promotion: just fun and games? |
| cord-301833-q8jiep32 | Complex immune dysregulation in COVID-19 patients with severe respiratory failure Role of innate and adaptive immunity in obesity- associated metabolic disease Obesity cardiomyopathy: pathogenesis and pathophysiology Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid? |
| cord-301833-q8jiep32 | What Is a Serious Advers Event? |
| cord-277803-7p1qu2rf | How should we prioritise whom to serve first with limited resources? |
| cord-277803-7p1qu2rf | Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials Consensus recommendations for the management of diabetes in patients with COVID-19 Diets with high or low protein content and glycemic index for weight- loss maintenance Two- year sustained weight loss and metabolic benefits with controlled- release phentermine/ topiramate in obese and overweight adults( SEQUEL): a randomized, placebo- controlled, phase 3 extension study Weight loss with naltrexone SR/ bupropion SR combination therapy as an adjunct to behavior modification: the COR- BMOD trial XENical in the prevention of diabetes in obese subjects( XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double- blind trial Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery( GRAVITAS): a randomised, double- blind, placebo- controlled trial Joint international consensus statement for ending stigma of obesity Bariatric, metabolic, and diabetes surgery: what's in a name? |
| cord-291627-5dqwyd9r | : what is the evidence? |
| cord-291627-5dqwyd9r | Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus- EMC COVID-19 and Diabetes: Can DPP4 inhibition play a role? |
| cord-261891-yiiz9s53 | : a narrative review Body mass index is associated with the development of acute respiratory distress syndrome Obesity and ARDS: Opportunity for Highly Personalized Mechanical Ventilation? |
| cord-277074-1emlkii0 | : how do we treat it? |
| cord-277074-1emlkii0 | Deleterious? |
| cord-318391-2s0rjfn8 | With COVID-19 Acute Pulmonary Embolism and COVID-19 Increased severity of COVID-19 in people with obesity: are we overlooking plausible biological mechanisms? |
| cord-318391-2s0rjfn8 | coagulopathy? |
| cord-338317-ro041w5l | How might the metabolic state of obesity intersect with and exacerbate pathological mechanisms 147 in COVID-19? 148 Enhanced production of cytokines. |
| cord-338317-ro041w5l | Might AT2 271 cells that have excess lipid be less able to switch to aerobic glycolysis and thus be more prone to cell 272 death during viral infection? |
| cord-338317-ro041w5l | What are obese patients with COVID-19 dying from? |
| cord-338317-ro041w5l | When two pandemics meet: Why is obesity associated with increased COVID-19 mortality? |
| cord-338317-ro041w5l | have a similar impact on other forms of viral pneumonia? |
| cord-012493-pwbzffo9 | : What Are the Connections? |
| cord-012493-pwbzffo9 | Comparison of waist- to- hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE Impact of obesity on total and cardiovascular mortality- fat or fiction? |
| cord-012493-pwbzffo9 | Preference or Genetic Personalization? |
| cord-012493-pwbzffo9 | The Accumulating Data to Optimally Predict Obesity Treatment( ADOPT) Core Measures Project: rationale and Approach A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk Childhood obesity: a review of increased risk for physical and psychological comorbidities Using maximum weight to redefine body mass index categories in studies of the mortality risks of obesity Current obesity, steady weight change and weight fluctuation as predictors of physical functioning in middle aged office workers: the Whitehall II Study Weight- loss history as a predictor of obesity treatment outcome: prospective, long- term results from behavioral, group self- help treatment Does weight cycling promote obesity and metabolic risk factors? |
| cord-012493-pwbzffo9 | maximal aerobic capacity Is low VO2max/ kg in obese heart failure patients indicative of cardiac dysfunction? |
| cord-288255-p8uzrsbd | ( COVID-19) Infection in Wuhan, China Systematic review or meta- analysis? |
| cord-288255-p8uzrsbd | COVID-19 and Italy: what next? |
| cord-288255-p8uzrsbd | Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-288255-p8uzrsbd | Circulation Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-288255-p8uzrsbd | Linking Obesity and Cardiovascular Disease across the Life- Course? |
| cord-288255-p8uzrsbd | The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-333368-kjrk8nn9 | : Why Children Fare Better than Adults? |
| cord-333368-kjrk8nn9 | COVID-19? Association between BMI and COVID-19 hospitalization by age Meta- inflammaging at the crossroad of geroscience Pathophysiology of COVID-19 |
| cord-333368-kjrk8nn9 | Does hyperglycemia worsen COVID-19 or does COVID-19 lead to immune pancreatic damage leading to hyperglycemia? |
| cord-333368-kjrk8nn9 | Is testosterone a key factor? |
| cord-333368-kjrk8nn9 | Sex differences in obesity, lipid metabolism, and inflammation- A role for the sex chromosomes? |
| cord-333368-kjrk8nn9 | The species Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS- CoV-2 COVID-19 and comorbidities: A role for dipeptidyl peptidase 4( DPP4) in disease severity? |
| cord-333368-kjrk8nn9 | factors associated with COVID-19 death in 17 million patients Can body mass index predict clinical outcomes for patients with acute lung injury/ acute respiratory distress syndrome? |
| cord-300991-ipy24zxp | 2020, 9, x FOR PEER REVIEW 4 of 12 buds or nasal mucosal epithelia? |
| cord-300991-ipy24zxp | A Sixth Taste Modality? |
| cord-300991-ipy24zxp | COVID-19 patients not exhibit a change in ONS perception? |
| cord-300991-ipy24zxp | Can the strategies to alter the intestinal microbiota decrease the severity of SARS- CoV-2 infection? |
| cord-300991-ipy24zxp | Does SARS- CoV-2 infect taste buds or nasal mucosal epithelia? |
| cord-300991-ipy24zxp | Does this viral infection promote a particular microbiome in the gut and ONS epithelia? |
| cord-300991-ipy24zxp | Is there any genetic or epigenetic predisposition? |
| cord-300991-ipy24zxp | all the COVID-19 subjects not complain of the loss of smell? |
| cord-319580-awtp0mpg | Are certain therapies more effective for treatment of severe COVID-19 in obese pregnant women compared to lean or non- pregnant women? |
| cord-319580-awtp0mpg | Are the kinetics of viral clearance different in obese versus lean pregnant women? |
| cord-319580-awtp0mpg | Are viral loads higher of SARS- CoV-2 in obese versus lean pregnant women? |
| cord-319580-awtp0mpg | Can adipose tissue serve as a reservoir for SARS- CoV-2 viral infection through adipocyte ACE2 expression? |
| cord-319580-awtp0mpg | Can we design epidemiologic studies to further assess whether the risk of severe COVID-19 infection in obese pregnancy is directly related to obesity itself or to associated socioeconomic factors? |
| cord-319580-awtp0mpg | Does increased surveillance for COVID-19 in obese pregnant women improve health outcomes? |
| cord-319580-awtp0mpg | Does the second and third trimester of pregnancy represent a time of increased risk for severe COVID-19? |
| cord-319580-awtp0mpg | If yes, how does gestational age modify the effect of obesity on COVID-19 disease severity? |
| cord-319580-awtp0mpg | Is preterm birth more common in obese pregnant women with COVID-19 due to concern for respiratory compromise? |
| cord-319580-awtp0mpg | The role of adipose tissue immune cells in obesity and low- grade inflammation Adipocytes properties and crosstalk with immune system in obesity- related inflammation Inflamed fat: what starts the fire? |
| cord-319580-awtp0mpg | What is the mechanism of increased risk for severe COVID-19 disease in obese nonpregnant and pregnant women? |
| cord-316260-1t3ifsfi | ( COVID-19) in the US Projecting the impact of the coronavirus disease-19 pandemic on childhood obesity in the United States: a microsimulation model Effects of COVID-19 lockdown on lifestyle behaviors in children with obesity living in Verona, Italy: a longitudinal study Can exercise affect immune function to increase susceptibility to infection? |
| cord-316260-1t3ifsfi | A pilot study of cardiorespiratory fitness, adiposity, and cardiometabolic health in youth with overweight and obesity Should patients with obesity be more afraid of COVID-19? Association of pediatric obesity and asthma, pulmonary physiology, metabolic dysregulation and the role of weight management Obesity phenotype is a predictor of COVID-19 disease susceptibility Obesity and childhood asthma in male schoolchildren in Saudi Arabia: is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21? |
| cord-316260-1t3ifsfi | A pilot study of cardiorespiratory fitness, adiposity, and cardiometabolic health in youth with overweight and obesity Should patients with obesity be more afraid of COVID-19? Association of pediatric obesity and asthma, pulmonary physiology, metabolic dysregulation and the role of weight management Obesity phenotype is a predictor of COVID-19 disease susceptibility Obesity and childhood asthma in male schoolchildren in Saudi Arabia: is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21? |
| cord-316260-1t3ifsfi | COVID-19 and obesity: links and risks Obesity- related glomerulopathy: clinical and pathologic characteristics and pathogenesis Nephrolithiasis in the obese patient Lipid accumulation and chronic kidney disease Obesity- related glomerulopathy: a latent change in obesity requiring more attention Renoprotective effects of ET(A) receptor antagonists therapy in experimental non- diabetic chronic kidney disease: is there still hope for the future? |
| cord-316260-1t3ifsfi | Higher body mass index is associated with iron deficiency in children 1 to 3 years of age Relationship between obesity and iron deficiency anemia: is there a role of hepcidin? |
| cord-316260-1t3ifsfi | Renin- angiotensin- aldosterone system and COVID-19 infection Is the kidney a target of SARS- CoV-2? |
| cord-316260-1t3ifsfi | The impact of childhood and adolescent obesity on cardiovascular risk in adulthood: a systematic review Ultrasonographic evaluation of the common carotid intima- media complex in healthy and overweight/ obese children Markers of subclinical atherosclerosis in schoolchildren with obesity and metabolic syndrome Endothelial cell infection and endotheliitis in COVID-19 Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity Insight into the relationship between obesity- induced low- level chronic inflammation and COVID-19 infection Metabolic inflammation and insulin resistance in obesity Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic COVID-19 related coagulopathy: a distinct entity? |
| cord-316260-1t3ifsfi | The obese child in the intensive care unit What evidence informs the nursing care of people with class iii obesity in an acute care setting? |
| cord-316260-1t3ifsfi | longitudinal associations between exclusive breastfeeding duration, child growth and obesity among WIC- participating children Coronavirus disease 2019 and children: what pediatric health care clinicians need to know The immune system and COVID-19: Friend or foe? |
| cord-316260-1t3ifsfi | why children fare better than adults? |
| cord-325055-todb1d4x | ( COVID-19) The impact of COVID-19 on bariatric surgery: re- defining psychosocial care Does high cardiorespiratory fitness confer some protection against proinflammatory responses after infection by SARS- CoV-2? |
| cord-325055-todb1d4x | American Heart Association Addresses Concerns Re: using RAAS antagonists in COVID-19-American College of Cardiology Obesity: the"Achilles heel"for COVID-19? |
| cord-325055-todb1d4x | Diabetes Metab Syndr Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic Vitamin D and obesity in adults: a pathophysiological and clinical update Could vitamin D reduce obesity- associated inflammation? |
| cord-325055-todb1d4x | Does COVID-19 disprove the obesity paradox in ARDS? |
| cord-325055-todb1d4x | Does workout intensity matter? |
| cord-325055-todb1d4x | High positive end- expiratory pressure is associated with improved survival in obese patients with acute respiratory distress syndrome Tracheal trauma after difficult airway management in morbidly obese patients with COVID-19 Obesity- induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury Obesity and susceptibility to severe outcomes following respiratory viral infection Obesity and respiratory infections: does excess adiposity weigh down host defense? |
| cord-325055-todb1d4x | Iwona title: Should patients with obesity be more afraid of COVID‐19? date: 2020- 06- 24 journal: |
| cord-325055-todb1d4x | Krela- Kaźmierczak I. Should patients with obesity be more afraid of COVID-19? |
| cord-325055-todb1d4x | Obesity Respiratory function and the obesity paradox BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta- analysis of clinical trials Should we treat obesity in COPD? |
| cord-325055-todb1d4x | Obesity phenotypes and their paradoxical association with cardiovascular diseases Are metabolically healthy obese patients also hemorheologically healthy? |
| cord-325055-todb1d4x | Targeting the adipose tissue in COVID-19 COVID-19, SARS and MERS: are they closely related? |